BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17849486)

  • 21. Dense lymphocytic infiltrates associated with non-melanoma skin cancer in patients with chronic lymphocytic leukemia.
    Wilson ML; Elston DM; Tyler WB; Marks VJ; Ferringer T
    Dermatol Online J; 2010 Mar; 16(3):4. PubMed ID: 20233561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia.
    Dezorella N; Kay S; Baron S; Shapiro M; Porat Z; Deutsch V; Herishanu Y; Katz BZ
    Cytometry B Clin Cytom; 2016 May; 90(3):257-66. PubMed ID: 26082241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL).
    Mulligan CS; Thomas ME; Mulligan SP
    Blood; 2009 Jun; 113(25):6496-7; author reply 6497-8. PubMed ID: 19541838
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality control in immunophenotyping. Use of human CD4+ and CD8+ T clones as standards.
    Kunkl A; Valle MT; Fenoglio D; Manca F
    Ann N Y Acad Sci; 1993 Mar; 677():417-9. PubMed ID: 8494229
    [No Abstract]   [Full Text] [Related]  

  • 25. A standardized ZAP-70 assay--lessons learned in the trenches.
    Shults KE; Miller DT; Davis BH; Flye L; Hobbs LA; Stelzer GT
    Cytometry B Clin Cytom; 2006 Jul; 70(4):276-83. PubMed ID: 16906586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The detection of minimal residual disease status in chronic lymphocytic leukemia.
    Marti GE
    Cytometry B Clin Cytom; 2011 Nov; 80(6):344-5. PubMed ID: 22002904
    [No Abstract]   [Full Text] [Related]  

  • 27. Steric hindrance: A practical (and frequently forgotten) problem in flow cytometry.
    Matos DM
    Cytometry B Clin Cytom; 2021 Jul; 100(4):397-401. PubMed ID: 33052633
    [No Abstract]   [Full Text] [Related]  

  • 28. ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue.
    Marti G; Orfao A; Goolsby C
    Cytometry B Clin Cytom; 2006 Jul; 70(4):197-200. PubMed ID: 16906575
    [No Abstract]   [Full Text] [Related]  

  • 29. Analyzing B cell chronic lymphocytic leukemia with Oncomark tubes on a FACSCanto.
    Warzynski MJ; Rawlings PL
    Cytometry B Clin Cytom; 2007 Sep; 72(5):418-22. PubMed ID: 17226864
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoclonal antibodies against Epstein-Barr virus transformed B lymphocytes from a CLL patient.
    Guha AK; Ghose T; Luner SJ; Nolido-Cruz H; Uniyal S; Rajaraman R; Fernandez LA; Lee SS; Lee CL
    Hybridoma; 1990 Apr; 9(2):119-32. PubMed ID: 2161403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
    Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
    Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
    Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
    Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
    Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
    Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied.
    Wilhelm C; Neubauer A; Brendel C
    Cytometry B Clin Cytom; 2006 Jul; 70(4):242-50. PubMed ID: 16906574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia.
    Nishii K; Katayama N; Mitani H; Matsumoto T; Miwa H; Kita K; Shiku H
    Int J Hematol; 2000 Jan; 71(1):59-65. PubMed ID: 10729995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic lymphocytic leukemia with peripheral T lymphocytes expressing CD 2+, CD 3+, CD 4-, CD 8-, CD 16+, and CD 56+ and lymph-node lymphocytes expressing CD 2+, CD 3-, CD 4-, CD 8-, CD 16+, CD 38+, and CD 56+].
    Furukawa Y; Tanaka K; Hasuike T; Hirai M; Masuzawa K; Ohira H; Ota K; Yasui Y; Nakao Y; Inoue T
    Rinsho Byori; 1991 May; 39(5):557-61. PubMed ID: 1712868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of interlaboratory variability in flow cytometric immunophenotyping by standardization of instrument set-up and calibration, and standard list mode data analysis.
    Gratama JW; Kraan J; Adriaansen H; Hooibrink B; Levering W; Reinders P; Van den Beemd MW; Van der Holt B; Bolhuis RL
    Cytometry; 1997 Feb; 30(1):10-22. PubMed ID: 9056737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia.
    Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.